VARIXA Film-coated tablet Ref.[115279] Active ingredients: Rivaroxaban

Source: Health Products Regulatory Authority (ZA)  Publisher: Innovata Pharmaceuticals (Pty) LTD, Crownwood Office Park, 100 Northern Parkway, Ormonde, Johannesburg, 2091, South Africa

Product name and form

VARIXA 15, (FILM COATED TABLETS).

VARIXA 20, (FILM COATED TABLETS).

Pharmaceutical Form

Film coated tablets.

VARIXA 15 round brown, biconvex film coated tablets, debossed with “504” on one side and plain on the other side.

VARIXA 20 triangle shaped, brown, film coated tablets, debossed with “505” on one side and plain on the other side.

Qualitative and quantitative composition

Each VARIXA 15 film-coated tablet contains rivaroxaban 15 mg.

Contains sugar (lactose – 31.5 mg per 15 mg tablet).

Each VARIXA 20 film-coated tablet contains rivaroxaban 20 mg.

Contains sugar (lactose – 42.0 mg per 20 mg tablet).

For the full list of excipients, see section 6.1.

Active Ingredient

Rivaroxaban is a highly selective direct factor Xa inhibitor with oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

List of Excipients

VARIXA 15: Lactose monohydrate, croscarmellose sodium, hypromellose, sodium lauryl sulphate, colloidal silicon dioxide, magnesium stearate, opadry brown, titanium dioxide, macrogol/peg, iron oxide red, ferrosoferric oxide (NF) black.

VARIXA 20: Lactose monohydrate, croscarmellose sodium, hypromellose, sodium lauryl sulphate, colloidal silicon dioxide, magnesium stearate, opadry brown, titanium dioxide, macrogol/peg, iron oxide red, ferrosoferric oxide (NF) black.

Pack sizes and marketing

VARIXA (rivaroxaban) film-coated tablets are available as follows: A carton containing aluminium foil and transparent PVC/PVDC blister strips containing 10 tablets each.

Marketing authorization holder

Innovata Pharmaceuticals (Pty) LTD, Crownwood Office Park, 100 Northern Parkway, Ormonde, Johannesburg, 2091, South Africa

Marketing authorization dates and numbers

29 MARCH 2022

Drugs

Drug Countries
VARIXA South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.